Review



unblinded dexcom g7 sensor  (Dexcom Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Dexcom Inc unblinded dexcom g7 sensor
    Unblinded Dexcom G7 Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g7+sensor/pm42092238-19-34-35
    Average 86 stars, based on 1 article reviews
    unblinded dexcom g7 sensor - by Bioz Stars, 2026-09
    86/100 stars

    Images

    Related Articles

    other:

    Article Title: Glycaemic Metrics Improve Significantly Within 7 Days of Continuous Glucose Monitoring Initiation in Non-Insulin-Using People With Type 2 Diabetes.
    Article Snippet: In brief, after a 7- to 10- day blinded CGM wear period with a physically blinded Dexcom G7 sensor (Dexcom Inc., San Diego, CA), participants were randomized to initiate real- time CGM with an unblinded Dexcom G7 sensor using either the NFA or SDA.

    Article Title: Clinical accuracy of Dexcom G6 and G7 continuous glucose monitors in hospitalized pediatric patients with type 1 diabetes: a real-world study.
    Article Snippet: Dexcom G6 and G7 sensors (Dexcom Inc., San Diego, CA, USA) provided factory-calibrated interstitial glucose readings at 5-min intervals and stored the values on a receiver or smartphone application.14 Raw sensor files were exported from Dexcom Clarity (a Cloud platform) as commaseparated value (CSV) files.15 Reference BG values were obtained using the BAROzen H Expert Plus BG monitoring system (Handok, Seoul, Korea), which employs a glucose dehydrogenase-flavin adenine dinucleotide enzymatic method and meets the ISO 15197:2013 performance criteria.16 All BG readings were automatically transmitted to the hospital electronic medical records.

    Article Title: Clinical accuracy of Dexcom G6 and G7 continuous glucose monitors in hospitalized pediatric patients with type 1 diabetes: a real-world study.
    Article Snippet: Of these, 1,106 pairs (59.9%) from Dexcom G6 sensors and 740 (40.1%) from G7 sensors.

    Article Title: AI-enhanced non-invasive monitoring of critical biochemical analytes in perioperative care: a review of signal processing and clinical applications
    Article Snippet: The Dexcom G7 sensor, placed on the arm, demonstrates the highest accuracy among currently available devices, with 95.3% of monitoring data exhibiting an error rate of ≤20% and the lowest mean absolute relative difference (MARD) of 8.2% (A MARD <15% is considered indicative of accuracy comparable to fingerstick blood glucose testing.).

    Article Title: CGM accuracy and reliability compared to point of care testing in older inpatients with comorbid type 2 diabetes and cognitive impairment
    Article Snippet: All participants were naive to CGM and were asked to wear blinded Dexcom G7 sensors for up to 10 days.

    Injection:

    Article Title: Multi-Patient Analysis of Steroid-Induced Hyperglycemia in Diabetic Patients Using Continuous Glucose Monitoring
    Article Snippet: .. Each patient was fitted with a Dexcom G7 CGM sensor immediately before the injection, and the standard steroid injection was administered 15 to 30 minutes of sensor placement. .. The CGM device was paired via Bluetooth with the patient’s smartphone using the Dexcom Clarity mobile app, enabling glucose monitoring at five-minute intervals over 10 days.



    Similar Products

    dexcom cgm sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom cgm sensor
    Dexcom Cgm Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/cgm+sensors/pm42156180-52-2-2
    Average 86 stars, based on 1 article reviews
    dexcom cgm sensor - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dexcom g7 cgm sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g7 cgm sensor
    Dexcom G7 Cgm Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g7+sensor/pm42156180-106-2-2
    Average 86 stars, based on 1 article reviews
    dexcom g7 cgm sensor - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dexcom g4 platinum sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g4 platinum sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom G4 Platinum Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g4+platinum/med_rxiv__64898__2026__05__13__26353094-140-16-16
    Average 86 stars, based on 1 article reviews
    dexcom g4 platinum sensor - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dexcom sensors  (Dexcom Inc)
    86
    Dexcom Inc dexcom sensors
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom Sensors, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+sensors/med_rxiv__64898__2026__05__13__26353094-32-26-26
    Average 86 stars, based on 1 article reviews
    dexcom sensors - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dexcom g6 sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g6 sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom G6 Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g6+sensor/pm42108404-47-3-6
    Average 86 stars, based on 1 article reviews
    dexcom g6 sensor - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    unblinded dexcom g7 sensor  (Dexcom Inc)
    86
    Dexcom Inc unblinded dexcom g7 sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Unblinded Dexcom G7 Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g7+sensor/pm42092238-19-34-35
    Average 86 stars, based on 1 article reviews
    unblinded dexcom g7 sensor - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dexcom g7 sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g7 sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom G7 Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g7+sensor/pmc13128380-112-1-1
    Average 86 stars, based on 1 article reviews
    dexcom g7 sensor - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dexcom sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+sensor/pmc13065641-82-22-22
    Average 86 stars, based on 1 article reviews
    dexcom sensor - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier
    dexcom g4 sensor  (Dexcom Inc)
    86
    Dexcom Inc dexcom g4 sensor
    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom <t>G4</t> Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.
    Dexcom G4 Sensor, supplied by Dexcom Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dexcom+sensor/dexcom+g4+sensor/pmc13065641-63-9-9
    Average 86 stars, based on 1 article reviews
    dexcom g4 sensor - by Bioz Stars, 2026-09
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom G4 Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.

    Journal: medRxiv

    Article Title: Prevalence, duration, and clinical implications of Continuous Glucose Monitor (CGM) measurement limit capping in type 1 diabetes

    doi: 10.64898/2026.05.13.26353094

    Figure Lengend Snippet: Proposed amended reporting format for CGM sensor measurement limit capping, illustrated using two exemplar 14-day windows from the Aleppo 2017 Replace-BG trial (Dexcom G4 Platinum) for the participant with the highest proportion of upper-limit capped readings (A-D) and the participant with the highest proportion of lower-limit capped readings (E-H). Panels A and E show the ambulatory glucose profile (AGP) with median glucose (red line) and shaded 25–75% and 10–90% interpercentile ranges. Grey shaded bands above and below the dashed device detection limit lines (400 and 40 mg/dL) indicate the glucose range that cannot be measured by the device. Panels B and F show glucose-range exposure as a stacked bar chart, with black segments at the top and bottom representing readings at or beyond the device detection limits, extending the standard display. Panels C and G summarise conventional window-level metrics alongside device-limit capping statistics (frequency and longest run duration), and panels D and H show the glucose frequency distribution with lower and upper capped bins shaded black. These display elements are proposed as optional additions to standard CGM reporting software, to be shown only when capping is present.

    Article Snippet: Our BGM comparison is restricted to a single arm of a single trial using the older Dexcom G4 Platinum sensor (mean absolute relative difference (MARD) ∼14%), which has lower accuracy than the Dexcom G6 (MARD ∼9%) used in three of our four datasets.

    Techniques: Software